<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CB05C424-91BF-4B48-9472-E6F6226A6A05"><gtr:id>CB05C424-91BF-4B48-9472-E6F6226A6A05</gtr:id><gtr:name>University of London</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Malet Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Structural Molecular Biology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CB05C424-91BF-4B48-9472-E6F6226A6A05"><gtr:id>CB05C424-91BF-4B48-9472-E6F6226A6A05</gtr:id><gtr:name>University of London</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Malet Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0D183607-45B3-463F-9D66-4925D5D4CC4B"><gtr:id>0D183607-45B3-463F-9D66-4925D5D4CC4B</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:surname>Ridley</gtr:surname><gtr:orcidId>0000-0001-8186-5708</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FE004083%2F1"><gtr:id>47D57D10-82E7-4B16-8028-9E33DA5E1780</gtr:id><gtr:title>Regulation of ROCK serine/threonine kinases by Rnd proteins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E004083/1</gtr:grantReference><gtr:abstractText>In mammals, cells need to move during development, wound healing and in response to infection. Cell movement is driven by the cytoskeleton, principally by filaments made of actin molecules. Part of cell movement involves contractile forces, which are generated by myosin filaments moving along actin filaments. Similar interactions between myosin and actin filaments generate muscle contraction. The ability of myosin filaments to move along actin filaments is increased by a protein called ROCK-I. Several human diseases could be treated by chemicals that inhibit ROCK-I, including heart disease, Alzheimers' disease and some cancers. We have identified a protein in cells, called RhoE, that binds to and inhibits ROCK-I, and thus reduces the interaction of myosin filaments with actin filaments. We want to understand more about how RhoE inhibits ROCK-I, and predict that this will help in the design of new chemicals to inhibit ROCK-I.</gtr:abstractText><gtr:technicalSummary>ROCK-I and ROCK-II are serine/threonine kinases that phosphorylate a number of proteins involved in regulating the actin cytoskeleton and actomyosin-based contractility. They thereby contribute to muscle contraction, cell migration, phagocytosis, and cell-cell junction integrity. RhoE is an atypical Rho family GTP-binding protein that binds to and inhibits ROCK-I but not ROCK-II. ROCK-I in turn phosphorylates RhoE and thereby induces its translocation from intracellular membrane to the cytosol and increases its stability. We propose to investigate the molecular basis for RhoE inhibition of ROCK-I, by mapping the regions of RhoE required for ROCK-I inhibition. In addition, we will determine where RhoE interacts with and inhibits ROCK-I in a variety of mammalian cell types, and how this interaction is regulated by extracellular stimuli. We will also investigate how phosphorylation alters RhoE localization and leads to increased stability, and whether RhoE interaction with other proteins affects its ability to inhibit ROCK-I. Furthermore, we will investigate whether there are other post-translational modifications on RhoE apart from phosphorylation, and if so how they affect its function. Finally, we will compare the responses of mammalian cells to RhoE with those to its closest relatives, Rnd1 and Rnd2, which do not bind to or inhibit ROCK-I/II.</gtr:technicalSummary><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>280879</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>Rnd3 interaction with 14-3-3 proteins</gtr:description><gtr:id>EB58E3E8-0B51-4355-BD9B-38526FCA05CC</gtr:id><gtr:impact>Publication:Cell. 2013 Apr 25;153(3):640-53. doi: 10.1016/j.cell.2013.03.044.
14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins.

Riou P1, Kj&amp;aelig;r S, Garg R, Purkiss A, George R, Cain RJ, Bineva G, Reymond N, McColl B, Thompson AJ, O'Reilly N, McDonald NQ, Parker PJ, Ridley AJ.</gtr:impact><gtr:partnerContribution>They synthesized peptides, carried out biophysical analysis of the interactions of the peptides with 14-3-3 proteins, and solved the crystal structure of the peptides with 14-3-3.</gtr:partnerContribution><gtr:piContribution>The collaboration involves biophysical analysis of Rnd3 interaction with 14-3-3 proteins</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cancer Research UK (ICR)</gtr:department><gtr:description>Mass spectrometry analysis of Rnd3</gtr:description><gtr:id>78613D7A-C3C3-4493-8AB4-1831809EFE4B</gtr:id><gtr:impact>Publication: 
Cell. 2013 Apr 25;153(3):640-53. doi: 10.1016/j.cell.2013.03.044.

14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins.

Riou P1, Kj&amp;aelig;r S, Garg R, Purkiss A, George R, Cain RJ, Bineva G, Reymond N, McColl B, Thompson AJ, O'Reilly N, McDonald NQ, Parker PJ, Ridley AJ.</gtr:impact><gtr:partnerContribution>We provided cell samples for analysis</gtr:partnerContribution><gtr:piContribution>Methods to identify farnesylated C-terminal peptides of Rnd3 were developed</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Proneural transcription factors regulate different steps of cortical neuron migration through Rnd-mediated inhibition of RhoA signaling.</gtr:description><gtr:id>5ABD3020-6863-4397-9B4D-A32647490349</gtr:id><gtr:impact>Publications in journals:
Neuron. 2011 Mar 24;69(6):1069-84. doi: 10.1016/j.neuron.2011.02.018.

Proneural transcription factors regulate different steps of cortical neuron migration through Rnd-mediated inhibition of RhoA signaling.

Pacary E1, Heng J, Azzarelli R, Riou P, Castro D, Lebel-Potter M, Parras C, Bell DM, Ridley AJ, Parsons M, Guillemot F.

Nat Commun. 2014 Feb 27;5:3405. doi: 10.1038/ncomms4405.

An antagonistic interaction between PlexinB2 and Rnd3 controls RhoA activity and cortical neuron migration.

Azzarelli R1, Pacary E1, Garg R2, Garcez P3, van den Berg D3, Riou P4, Ridley AJ2, Friedel RH5, Parsons M2, Guillemot F3.</gtr:impact><gtr:partnerContribution>The partners contributed the research identifying Rnd proteins as targets for transcription factors in the neuronal cortex and in vivo studies of their functions during cortical development.</gtr:partnerContribution><gtr:piContribution>A new collaboration between the laboratories of Dr Francois Guillemot at MRC NIMR and Prof Anne Ridley resulted in two publications. The Ridley laboratory contributed Rnd plasmids and expertise on Rnd/Rho/ROCK signalling.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Open days - King's College London</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D8FA7E30-1B69-46CE-8AA6-CF443B22815E</gtr:id><gtr:impact>A-level students and their parents visit King's College London to find out about courses and research. We take groups on guided tours of our laboratories and describe our research to them.

Increased awareness that universities carry out research as well as teach undergraduates</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have shown that the serine/threonine kinases ROCK and PKC phosphorylate Rnd3, and identified the residues phosphorylated by a combination of mutagenesis and mass spectrometry. We have also shown that Rnd1 and Rnd2 can be phosphorylated in cells. We have found that phosphorylated Rnd3 binds to 14-3-3 proteins, and that this binding inhibits Rnd3 activity by translocating it from membranes to the cytosol. This involves phosphorylation of 2 residues on Rnd3 by ROCK and 1 residue by PKC. 

 When Rnd3 is bound to its target p190RhoGAP, it is not phosphorylated, indicating that it exists in two separate complexes: an active complex with p190RhoGAP, and an inactive complex with 14-3-3.



Rnd3 is also post-translationally modified by addition of a lipid farnesyl group at the C-terminus. We have shown that farnesylation as well as phosphorylation is required for Rnd3 to interact with 14-3-3 proteins. In collaboration with Neil McDonald, we have solved the crystal structure of Rnd3 with 14-3-3 proteins.</gtr:description><gtr:exploitationPathways>ROCK inhibitors are already in use clinically in Japan. PKC inhibitors are being considered for clinical use. This information on Rnd3, ROCK and PKC, is relevant to the interpretation of clinical results. Rnd3 regulates cell migration and cell contractility and thus methods to incrrease its activity, for example by inhibiting its phosphorylation, could be used to promote cell migration and/or cell contractility. This information on Rnd3 regulation will be relevant to the design and use of ROCK or PKC inhibitors in pre-clinical or clinical settings.

In addition, our novel results on farnesyl involvement in the interaction with 14-3-3 proteins will be useful for the academic community studying a wide variety of other prenylated proteins.</gtr:exploitationPathways><gtr:id>481DAF13-0E9C-4856-9DE0-F5C8ADEAE818</gtr:id><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Multiple constructing encoding Rnd1, Rnd2, Rnd3 chimerae, and Rnd1, Rnd2 and Rnd3 point mutations.</gtr:description><gtr:id>392FEC72-33F5-4914-924C-F119199C61F1</gtr:id><gtr:impact>Joint research publications: Madigan et al., Biochemical Journal 2009
Leibig et al., Mol Biol Cell 2009</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Rnd1, Rnd2, Rnd3 mutants</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8437E13D-96DD-4498-8B07-A59DDEEF1A33"><gtr:id>8437E13D-96DD-4498-8B07-A59DDEEF1A33</gtr:id><gtr:title>Rnd3 induces stress fibres in endothelial cells through RhoB.</gtr:title><gtr:parentPublicationTitle>Biology open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e731634785d1407baedea4545943dd1"><gtr:id>3e731634785d1407baedea4545943dd1</gtr:id><gtr:otherNames>Gottesb?hren U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-6390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/506DFD10-92D0-4D94-BA18-97E9F88FC051"><gtr:id>506DFD10-92D0-4D94-BA18-97E9F88FC051</gtr:id><gtr:title>Regulation of Rnd3 localization and function by protein kinase C alpha-mediated phosphorylation.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8573b4a3813b82bb05c1f50556ebe99b"><gtr:id>8573b4a3813b82bb05c1f50556ebe99b</gtr:id><gtr:otherNames>Madigan JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3FAD60C-3FA5-4A97-ACB0-1226BBB4B2BF"><gtr:id>A3FAD60C-3FA5-4A97-ACB0-1226BBB4B2BF</gtr:id><gtr:title>Cdc42 promotes transendothelial migration of cancer cells through ?1 integrin.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ef3d2c17042247d693f7dcb50880111"><gtr:id>7ef3d2c17042247d693f7dcb50880111</gtr:id><gtr:otherNames>Reymond N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E6985FF-EE69-432C-A375-464817D72C13"><gtr:id>6E6985FF-EE69-432C-A375-464817D72C13</gtr:id><gtr:title>Rnd3-induced cell rounding requires interaction with Plexin-B2.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ec83cd02b8a52413a21156e0325e9e31"><gtr:id>ec83cd02b8a52413a21156e0325e9e31</gtr:id><gtr:otherNames>McColl B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB0ADC7F-3D65-43E6-9D9E-166B2255AB2D"><gtr:id>FB0ADC7F-3D65-43E6-9D9E-166B2255AB2D</gtr:id><gtr:title>An antagonistic interaction between PlexinB2 and Rnd3 controls RhoA activity and cortical neuron migration.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2f26d54a3ced3310bae19e29b38dd4bd"><gtr:id>2f26d54a3ced3310bae19e29b38dd4bd</gtr:id><gtr:otherNames>Azzarelli R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4E19D895-C0E1-461D-AFEB-B9749D7D8901"><gtr:id>4E19D895-C0E1-461D-AFEB-B9749D7D8901</gtr:id><gtr:title>Rho GTPases and cancer cell transendothelial migration.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ef3d2c17042247d693f7dcb50880111"><gtr:id>7ef3d2c17042247d693f7dcb50880111</gtr:id><gtr:otherNames>Reymond N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BE42679-E00F-47D7-A344-DE408435E400"><gtr:id>6BE42679-E00F-47D7-A344-DE408435E400</gtr:id><gtr:title>RhoE Is required for keratinocyte differentiation and stratification.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbc0a12b1d792d6fa2402802148bdce5"><gtr:id>fbc0a12b1d792d6fa2402802148bdce5</gtr:id><gtr:otherNames>Liebig T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D45C531-F02B-4A94-99C9-CBAC17B2E99A"><gtr:id>1D45C531-F02B-4A94-99C9-CBAC17B2E99A</gtr:id><gtr:title>14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0ae779d3595e95bd04bfedbdae44c10b"><gtr:id>0ae779d3595e95bd04bfedbdae44c10b</gtr:id><gtr:otherNames>Riou P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD3222E2-D2BB-44EE-BED7-97483DCFA20B"><gtr:id>BD3222E2-D2BB-44EE-BED7-97483DCFA20B</gtr:id><gtr:title>Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0ae779d3595e95bd04bfedbdae44c10b"><gtr:id>0ae779d3595e95bd04bfedbdae44c10b</gtr:id><gtr:otherNames>Riou P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1383A76B-86FA-4819-911E-65354E4B2496"><gtr:id>1383A76B-86FA-4819-911E-65354E4B2496</gtr:id><gtr:title>Proneural transcription factors regulate different steps of cortical neuron migration through Rnd-mediated inhibition of RhoA signaling.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c86da639ee9a679cd0f139d87c6c10d"><gtr:id>2c86da639ee9a679cd0f139d87c6c10d</gtr:id><gtr:otherNames>Pacary E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E004083/1</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>47D57D10-82E7-4B16-8028-9E33DA5E1780</gtr:id><gtr:grantRef>BB/E004083/1</gtr:grantRef><gtr:amount>280879.53</gtr:amount><gtr:start>2006-09-01</gtr:start><gtr:end>2007-03-31</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>3D46501B-0C79-47E2-9852-DB55868D64D8</gtr:id><gtr:grantRef>BB/E004083/2</gtr:grantRef><gtr:amount>225362.38</gtr:amount><gtr:start>2007-04-01</gtr:start><gtr:end>2009-08-31</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>